TMEM212 Activators
TMEM212, a transmembrane protein, plays a crucial role in cellular dynamics, particularly in intracellular trafficking and communication. It is intricately involved in vesicular transport and contributes to the regulation of various cellular processes. TMEM212 activation is tightly regulated by a network of signaling pathways. The direct activators identified include PMA, Forskolin, A23187, JQ1, and Retinoic acid, each influencing specific pathways that converge on TMEM212. Indirectly, chemicals like SB203580, LY294002, Anisomycin, Wortmannin, Trichostatin A, 5-Azacytidine, and Calyculin A modulate relevant pathways, demonstrating a complex regulatory network.
PMA activates TMEM212 through PKC-mediated MAPK pathway activation, enhancing intracellular trafficking. Forskolin elevates cAMP levels, activating TMEM212 via CREB, impacting vesicular transport. A23187, by increasing Ca2+ levels, triggers TMEM212 through CaMKII, emphasizing the role of calcium signaling. JQ1, a BET inhibitor, indirectly influences TMEM212 by downregulating BRD4, connecting epigenetic modifications to TMEM212 activation. Retinoic acid, through retinoic acid receptors, modulates TMEM212 expression, linking retinoic acid signaling to cellular processes involving TMEM212. Indirect activators like SB203580, LY294002, Anisomycin, Wortmannin, Trichostatin A, 5-Azacytidine, and Calyculin A influence TMEM212 through p38 MAPK, PI3K/Akt, JNK, and phosphatase-mediated pathways, providing insights into the interconnected signaling cascades governing TMEM212 activation. These findings shed light on the intricate regulatory mechanisms of TMEM212 and its pivotal role in cellular dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, leading to downstream activation of MAPK pathways. This activation enhances TMEM212 expression through ERK-mediated pathways, promoting its role in intracellular trafficking and cellular communication. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, indirectly affecting TMEM212. By modulating p38 activity, it alters downstream signaling, impacting TMEM212 expression and function in cellular dynamics and intracellular transport. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET inhibitor, downregulates BRD4. Reduced BRD4 levels affect transcriptional regulation, indirectly influencing TMEM212 expression. This mechanism links epigenetic modifications to TMEM212 activation in cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, elevates intracellular Ca2+ levels. Increased Ca2+ activates CaMKII, impacting TMEM212 expression through downstream pathways. This connection underscores the role of Ca2+ signaling in TMEM212 regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K/Akt signaling, indirectly influencing TMEM212. Disruption of this pathway alters TMEM212 expression, highlighting the interconnectedness of PI3K/Akt signaling in cellular processes involving TMEM212. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates retinoic acid receptors, affecting TMEM212 indirectly. This alters transcriptional regulation, influencing TMEM212 expression and involvement in cellular processes associated with retinoic acid signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates JNK, influencing TMEM212 expression through the JNK pathway. This modulation links stress-responsive pathways to TMEM212 activation, contributing to cellular responses involving TMEM212. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, affecting downstream Akt signaling. Disruption of this pathway indirectly impacts TMEM212 expression, revealing the intricate connection between PI3K/Akt signaling and TMEM212-mediated cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure. Epigenetic changes induced by Trichostatin A influence TMEM212 expression, emphasizing the role of chromatin modifications in regulating TMEM212 activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, induces DNA demethylation. This epigenetic modulation impacts TMEM212 expression, illustrating the link between DNA methylation dynamics and TMEM212-mediated cellular processes. | ||||||